-
1مراجعة
المؤلفون: Chocarro, Luisa, Bocanegra, Ana, Blanco, Ester, Fernández-Rubio, Leticia, Arasanz, Hugo, Echaide, Miriam, Garnica, Maider, Ramos, Pablo, Piñeiro-Hermida, Sergio, Vera, Ruth, Escors, David, Kochan, Grazyna, orcid:0000-0002-3508-0595, orcid:0000-0002-2980-7137, orcid:0000-0001-6838-6702, orcid:0000-0002-7371-1626, orcid:0000-0003-2828-4458
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35954196; info:eu-repo/semantics/altIdentifier/eissn/2073-4409; Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor, 2022, vol. 11, núm. 15; https://investigacion.unirioja.es/documentos/63138b62b8384f133e2d371cTest; urn:issn:2073-4409
الإتاحة: https://doi.org/10.3390/CELLS11152351Test
https://investigacion.unirioja.es/documentos/63138b62b8384f133e2d371cTest -
2دورية أكاديمية
المؤلفون: Dulal, Dharmindra, Boring, Andrew, Terrero, David, Johnson, Tiffany, Tiwari, Amit K, Raman, Dayanidhi
المصدر: Cancers (Basel) ; ISSN:2072-6694 ; Volume:15 ; Issue:10
مصطلحات موضوعية: CD8+ T lymphocytes, CTLA-4, LAG-3, PD-1, TIGIT, TIM-3, VISTA, immune checkpoints, immuno-refractory tumors, immunosuppression, immunotherapy
العلاقة: https://doi.org/10.3390/cancers15102774Test; https://pubmed.ncbi.nlm.nih.gov/37345111Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216651Test/
الإتاحة: https://doi.org/10.3390/cancers15102774Test
https://pubmed.ncbi.nlm.nih.gov/37345111Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216651Test/ -
3مراجعة
مصطلحات موضوعية: CTLA-4, PD-1, Melanoma, Prostate cancer, Kidney cancer, Bladder cancer, PD-L1, LAG-3
-
4